Controversy and Progress in Alzheimer’s Disease — FDA Approval of Aducanumab
Year: 2021
Type: article
Source: New England Journal of Medicine
DOI: 10.1056/nejmp2111320
Author: Gil D. Rabinovici
Institution: University of California, San Francisco
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3186275776